Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Equity Bancshares, Inc. (EQBK) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Equity Bancshares, Inc. (EQBK) - free report >>
Image: Bigstock
New Strong Sell Stocks for February 1st
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Brainsway (BWAY - Free Report) is a commercial stage medical device company which is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. The Zacks Consensus Estimate for its current year earnings has been revised almost 10.81% downward over the last 60 days.
CareMax (CMAX - Free Report) is a technology-enabled care platform providing value-based care and chronic disease management to seniors. The Zacks Consensus Estimate for its current year earnings has been revised 9.1% downward over the last 60 days.
Equity Bancshares (EQBK - Free Report) is a bank holding company primarily in Kansas and Missouri that provides financial services primarily to businesses, business owners and individuals. The Zacks Consensus Estimate for its current year earnings has been revised 5.5% downward over the last 60 days.
View the entire Zacks Rank #5 List.